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ABSTRACT
 Objective: Premna serratifolia L. locally called “Munnai” belongs to the family “Verbenaceae.” This study was carried out to identify the phyto 
components present in the ethanol extract of leaves by gas chromatography/mass spectrometry (GC/MS) analysis. Eight compounds were identified, 
and its mechanism of action was identified through docking analysis. Most of the drugs currently used for the breast cancer treatment produce side 
effects, and hence, we focused on plant-based compounds, which exhibit the minimum toxic effect.
Methods: Molecular docking, density function theory, pharmacophore modeling, and absorption, distribution, metabolism, excretion, and toxicity 
studies were performed for those plant compounds to analyze the antibreast cancer activity. Docking experiments were carried out between 
biocompounds from leaves with the target protein (Breast cancer [3S7S]) using Accelrys Discovery Studio 4.0.
Results: The result consists of eight compounds from leaves identified through GC/MS of which pentadecanoic acid, 13-methyl-methyl ester is 
considered as the lead compound due to its desirable interaction with the target protein. The Libdock score and binding energy are 62.708 and 
−17.7087, respectively.
Conclusion: All the compounds can be further explored for structural modification and detailed investigations to arrive at possibly newer potent 
agents with better therapeutic effects.
Keywords: Premna serratifolia L., Biocompounds, Docking, Pharmacophore, Absorption; distribution; metabolism; excretion; and toxicity, Density 
function theory, Breast cancer.
INTRODUCTION
Premna serratifolia L. (Verbenaceae) is an important woody, 
medicinal plant, and locally known as Munnai and has been used 
significantly and consistently in Ayurveda, Siddha, and Unani system 
of medicines (Fig. 1) [1-3]. The leaves have anticancer, astringent, 
anti-inflammatory, and antibacterial properties and are used in 
cardiac disorder, cough, leprosy, skin disease, constipation, fever, 
diabetes, obesity, stomach ache, and tumor [4-7]. It has cardiotonic, 







Species P. serratifolia L.
P. serratifolia: Premna serratifolia
Breast cancer is a serious health concern in India causing the highest 
mortality rate in females, which occurs due to uncontrolled cell 
division and can be metastasize to other parts of the human body. 
The available drugs and treatments are not satisfactory as they do 
not completely eradicate the cancerous cells from the body. Hence, 
newer and more effective drugs and treatments against breast cancer 
are the need of the hour. The plant-like P. serratifolia L. has strong 
structural activity with breast cancer human body cells [10-12]. 
Molecular docking was utilized to prove that similar compounds can 




P. serratifolia L. leaves were collected in clean polythene bags from 
Queen Mary’s College, Chennai. The plant was washed in tap water and 
shade dried for 20 days.
Preparation of extract
The fresh leaves were shade dried, powdered, and extracted (100 g) 
successively with 150 ml of ethanol (60-75°C) in a Soxhlet extractor for 
18-20 hrs. The extracts were filtered, and excess solvent was evaporated 
using rotary evaporator.
Analysis of active components using gas chromatography/mass 
spectrometry (GC/MS)
GC/MS is a method that combines the features of gas-liquid 
chromatography and MS to identify different substances within a test 
sample. GC/MS can provide meaningful information for components 
that are volatile, non-ionic, and thermally stable and have relatively low 
molecular weight. The crude ethanol extract of P. serratifolia L. leaves 
was analyzed by GC/MS. The instrument used for GC/MS analysis is 
“JEOL GCMATE II GC/MS” with data system which is a high resolution, 
double focusing instrument giving maximum resolution: 6000 and 
maximum calibrated mass: 1500 Daltons. The results obtained through 
GC/MS analysis is shown in Fig. 2.
Molecular docking studies
Docking software: Discovery Studio 4.0
Discovery Studio 4.0 is highly dynamic, and user-friendly software used 
for homology modeling, molecular dynamics, pharmacophore modeling, 
density function theory (DFT), molecular docking, and drug designing.
Research Article
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Fig. 1: Premna serratifolia L. plant
Fig. 2: Gas chromatography-mass spectrometry chromatograph of 
the leaves of Premna serratifolia L.
Table 1: Lipinski’s Rule of five for compound obtained from GC/MS analysis







1 2(1H)-benzocycloctenone, decahydro-10a-methyl-, trans- 0 1 194.313 3.477
2 Pentadecanoic acid, 13-methyl-, methyl ester 0 2 270.451 6.414
3 Hexadecanoic acid, ethyl ester 0 2 284.477 6.967
4 Phytol 1 1 296.531 7.337
5 14-hydroxy-15-methyl hexadec-15-enoic acid, ethyl ester 1 3 312.487 5.921
6 Cyclohexane-1-carboxlyic acid, 3-[3-[2-furyl]-1-oxopropyl]-6, 
6-dimethyl-2.4 dioxo-, methyl ester
0 6 322.353 1.394
7 3’,4’,5’-trimethoxyacetophenone (2-pyridylcarbonyl) 
hydrazone
1 7 329.35 1.892
8 Tetracosapentaene 2,6,10,15,19,23-hexamethyl 0 0 412.734 11.581
GC/MS: Gas chromatography/mass spectrometry
Protein preparation
The molecule taken is X-ray crystal structure of “human breast cancer 
protein,” Protein Data Bank (PDB) ID-3S7S, with resolution of 1.60 Å. 
The ligand and crystallographic water molecules are removed from 
the protein, and the chemistry of the protein was corrected for missing 
hydrogen by the software.
Ligand preparation
The compounds 2(1H)-benzocycloctenone, decahydro-10a-
methyl-, trans-, pentadecanoic acid, 13-methyl-, methyl ester, 
hexadecanoic acid, ethyl ester, phytol, 14-hydroxy-15-methyl 
hexadec-15-enoic acid, ethyl ester, cyclohexane-1-carboxlyic acid, 
3-[3-[2-furyl]-1-oxopropyl]-6,6-dimethyl-2.4 dioxo-, methyl ester, 
3’,4’,5’-trimethoxyacetophenone(2-pyridylcarbonyl)hydrazone, 
Tetracosapentaene. 2,6,10,15,19,23-hexamethyl obtained from GC/MS 
analysis results of leaf extract from P. serratifolia L. were taken. Hydrogen 
bonds were added, and the energy was minimized using CHARMm force 
field using the software.
“Lipinski rule of five” for eight ligand molecules
Using the Discovery Studio 4.0, molecular properties and drug-
likeness of the compounds were examined by “Lipinski’s Rule of 
Five,” formulated by Christopher. The molecular properties of the 
compounds are shown in Table 1, which satisfies the “Lipinski’s Rule 
of Five.”
RESULTS AND DISCUSSION
Based on the GC/MS analyses, the ethanolic extraction of leaves 
P. serratifolia L. contained numerous phytochemical compounds. The 
chemical components that had been identified, at various retention 
time during GC/MS analysis of the plant are summarized in Table 2, and 
the GC/MS chromatograms are presented in Fig. 3.
Molecular docking
The retrieved crystal structure from PDB (PDB ID 3S7S-Breast 
Cancer) has the structural weight as 16779.4. This protein has one 
chain, namely, “A” with 503 amino acid residues in length. Different 
compounds (ligands) from the plant leaves were docked with the 
breast cancer protein’s target residues (PRO 78, ASN 79, VAL 80, 
ASP 81, ARG 85, ILE 86, CYS 87, LEU 121, ALA 122, ASN 123) out of 
which pentadecanoic acid, 13-methyl-, methyl ester showed the best 
interaction with the active site receptors shown in Table 3. Docked 
pose of the different compounds with protein is presented in Table 3. 
Hydrogen, hydrophobic, and favorable interaction histograms of 
eight compounds with docked residues is shown in Fig. 4. The values 
of the compounds include Vander Waals energy, Cdocker Energy, 
Lig score 1 and 2, piecewise linear potential (PLP) - PLP1 and PLP2, 
Jain, potential of mean force presented in Table 4. The Libdock score, 
binding energy, hydrogen bond interaction and distance obtained 
using the ligand Fit protocol of Discovery Studio 4.0 are presented 
in Table 5.
The ligand (pentadecanoic acid, 13-methyl-, methyl ester) from leaves 
showed the highest dock score and hydrogen bond interaction with 
breast cancer protein target when compared to other ligands.
To ensure that the ligand orientation obtained from the docking 
studies was likely to represent valid and reasonable binding modes, 
the ligand fit program docking parameters had to be first validated for 
the crystal structure’s active site. Protein utilities and health protocol 
of Discovery Studio was used to find out if the active site containing 
amino acids such as PRO 78, ASN 79, VAL 80, ASP 81, ARG 85, ILE 86, 
CYS 87, LEU 121, ALA 122, and ASN 123. Results of docking showed 
that the compound binds to the active site residue, which indicates that 
these compounds can inhibit the breast cancer protein. Further clinical 
trials on P. serratifolia L. plant extracts are required to validate these 
compounds.
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Table 2: Phyto components identified in ethanolic extraction of the leaves of P. serratifolia L.
Peak Reaction time Compound identified Structure
1 16.23 2(1H)-benzocycloctenone, decahydro-10a-methyl-, trans-
2 17.22 Pentadecanoic acid, 13-methyl-, methyl ester
3 17.83 Hexadecanoic acid, ethyl ester
4 19.07 Phytol
5 18.75 14-hydroxy-15-methyl hexadec-15-enoic acid, ethyl ester
6 22.57 Cyclohexane-1-carboxlyic acid, 3-[3-[2-furyl]-1-oxopropyl]-6, 6-dimethyl-2.4 
dioxo-, methyl ester
7 24.75 3’,4’,5’-Trimethoxyacetophenone(2-pyridylcarbonyl)hydrazone
8 27.82 Tetracosapentaene 2,6,10,15,19,23-hexamethyl
P. serratifolia: Premna serratifolia
Table 3: Hydrogen bond interaction with breast cancer protein of plant leaves compounds
S.No Name Hydrogen bond interaction 2D diagram
1 2(1H)-benzocycloctenone, decahydro-10a-methyl-, trans-
2 Pentadecanoic acid, 13-methyl-, methyl ester
3 Hexadecanoic acid, ethyl ester
4 Phytol
5 14-hydroxy-15-methyl hexadec-15-enoic acid, ethyl ester
6 Cyclohexane-1-carboxlyic acid, 3-[3-[2-furyl]-1-oxopropyl]-6, 6-dimethyl-2.4 
dioxo-, methyl ester
7 3’,4’,5’-trimethoxyacetophenone (2-pyridylcarbonyl) hydrazone
8 Tetracosapentaene 2,6,10,15,19,23-hexamethyl - -
2D: Two-dimensional
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Table 4: P. serratifolia L. leaves results for protein-ligand interaction










-PLP1 -PLP2 Jain -PMF
1 2(1H)-benzocycloctenone, decahydro-10a-methyl-, trans- −3754.47 1.047 29.192 2.48 4.53 47.89 45.93 2.32 49.89
2 Pentadecanoic acid, 13-methyl-, methyl ester −3754.47 36.553 42.055 3.16 5.39 56.68 48.12 1.42 78.53
3 Hexadecanoic acid, ethyl ester −3754.47 48.28 49.22 2.07 5.18 70.04 64.65 3.19 69.95
4 Phytol −3754.47 14.949 46.572 4.2 5.6 81.41 80.06 2.84 84.3
5 14-hydroxy-15-methyl hexadec-15-enoic acid, ethyl ester −3754.47 32.048 52.967 4.04 6.3 92.19 84.92 2.64 85.62
6 Cyclohexane-1-carboxlyic acid, 3-[3-[2-furyl]-1-oxopropyl]-6, 
6-dimethyl-2.4 dioxo-, methyl ester
−3754.47 2.389 39.481 2.78 5 72.3 64.28 2.48 54.17
7 3’,4’,5’-trimethoxyacetophenone (2-pyridylcarbonyl) 
hydrazone
−3754.47 28.614 47.944 4.47 6.16 91.47 86.04 1.81 70.07
8 Tetracosapentaene 2,6,10,15,19,23-hexamethyl - - - - - - - - -
VWE: Vander Waals Energy, PLP: Piecewise linear potential, PMF: Potential of mean force, P. serratifolia: Premna serratifolia
Table 5: Hydrogen bond interaction between bioactive compounds and breast cancer protein












1 2(1H)-benzocycloctenone, decahydro-10a-methyl-, 
trans-




































5 14-hydroxy-15-methyl hexadec-15-enoic acid, ethyl 
ester










6 Cyclohexane-1-carboxlyic acid, 
3-[3-[2-furyl]-1-oxopropyl]-6, 6-dimethyl-2.4 dioxo-, 
methyl ester












7 3’,4’,5’-Trimethoxyacetophenone (2-pyridylcarbonyl) 
hydrazone








8 Tetracosapentaene 2,6,10,15,19,23-hexamethyl - - - - - -
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Table 7: Eight compounds from DFT molecular interaction
S.No Name HOMO interaction LUMO interaction MEP
1 2(1H)-benzocycloctenone, 
decahydro-10a-methyl-, trans-
2 Pentadecanoic acid, 13-methyl-, 
methyl ester
3 Hexadecanoic acid, ethyl ester
4 Phytol
5 14-hydroxy-15-methyl 
hexadec-15-enoic acid, ethyl 
ester
6 Cyclohexane-1-carboxlyic acid, 
3-[3-[2-furyl]-1-oxopropyl]-6, 






HOMO: Highest occupied molecular orbital, LUMO: Lowest unoccupied molecular orbitals, MEP: Molecular electrostatic potentials
Table 6: Molecular orbital calculations of eight compounds from DFT











1 2(1H)-Benzocycloctenone, decahydro-10a-methyl-, trans- −578.55928519 −6.55532286 −0.18610409 −0.05201516 1.55676472
2 Pentadecanoic acid, 13-methyl-, methyl ester −811.33717859 −9.24629928 −0.22871376 −0.03231323 0.51444295
3 Hexadecanoicacid, ethyl ester −850.28218855 −9.77688051 −0.22617830 −0.03014546 0.62677913
4 Phytol −853.40325194 −10.59188187 −0.18768254 −0.00133012 0.88125210
5 14-hydroxy-15-methyl hexadec-15-enoic acid, ethyl ester −962.71137806 −10.22204917 −0.20313798 −0.02904795 1.03587724
6 Cyclohexane-1-carboxlyic acid, 
3-[3-[2-furyl]-1-oxopropyl]-6, 6-dimethyl-2.4 dioxo-, 
methyl ester
−1103.04933836 −8.58649718 0.15291521 0.22139433 6.24029275
7 3’,4’,5’-trimethoxyacetophenone(2-pyridylcarbonyl) 
hydrazone
−1114.78437723 −8.40308616 −0.15336818 −0.09008000 2.62677957
8 Tetracosapentaene 2,6,10,15,19,23-hexamethyl −1163.30385239 −14.68380366 −0.17608521 −0.00060306 0.17139820
HOMO: Highest occupied molecular orbital, LUMO: Lowest unoccupied molecular orbitals, DFT: Density function theory
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DFT
DFT calculations were performed for eight compounds. Optimized 
molecular orbital calculations provide a detailed description of orbitals 
including spatial characteristics, nodal patterns, and individual atom 
contributions. The highest occupied molecular orbital (HOMO) orbitals 
are located on the substituted molecule, whereas lowest unoccupied 
molecular orbital (LUMO) orbitals resemble those obtained for the 
unsubstituted molecule, and therefore, the substitution has an influence 
on the electron donation ability, but only a small impact on electron 
acceptance ability. The orbital energy levels of HOMO and LUMO of eight 
compounds are listed in Table 6. The energy gaps can be seen between 
HOMO and LUMO of the compounds. The HOMO and LUMO energy gap 
explain interaction taking place within the molecules. Selected optimized 
geometrical parameters have been reported and HOMO, LUMO energies, 
and structures are elucidated and are shown in Table 7.
Pharmacophore modeling
Pharmacophores are the lead compound against the desired target. 
A pharmacophore is a three-dimensional (3D) arrangement of 
functional groups within a molecule which are essential for the 
compounds to bind with a macromolecule’s active site. Identification 
of the pharmacophore is an important step in understanding the 
interaction between receptor and ligand. The pharmacophore 
models produced were evaluated qualitatively through visual 
inspection. A pharmacophore query is comprised of different features 
representing molecular recognition motifs such as hydrogen bond 
acceptors or donors, anionic, cationic, hydrophobic, and aromatic 
groups (Fig. 5). The pharmacophore expresses constraints on the 3D 
structure of the molecule by specifying relative atom positions that 
should be maintained to increase the likelihood that the molecule will 
bind with the receptor site. For all the eight ligands, pharmacophores 
were generated as shown in Table 8. The content 2 of Table 8 shows 
pharmacophore model generated for pentadecanoic acid, 13-methyl-, 
methyl ester which is found to be having the best interactions with 
breast cancer protein indicating very good antibreast cancer effect. 
These could be further used for drug designing against breast cancer. 
The pharmacophore studies have also shown that these compounds 
are having very fewer side effects and thus can be further investigated 
through clinical trials.
Absorption, distribution, metabolism, excretion, and toxicity 
(ADMET)
The ADMET properties of the compounds with results are described in 
Fig. 6. Computer aided ADME studies have been done using the software 
(Accelrys Discovery Studio software). These studies are solely based 
on the chemical structure of the molecule. Some of the parameters 
that are calculated are Atom based Log P98 (A Log P98), polar surface 
area, blood brain barrier, and cytochrome P450. The physiochemical 
properties of novel compounds are shown in Table 9. Hence, there is a 
high probability that these compounds can be used as drugs to inhibit 
the desired target once clinically proven.Fig. 5. Pharmacophore query
Table 8: Interaction between pharmacophore model of eight ligands with breast cancer protein
S.No Name Pharmacophore modeling
1 2(1H)-benzocycloctenone, decahydro-10a-methyl-, trans-
2 Pentadecanoic acid, 13-methyl-, methyl ester
3 Hexadecanoic acid, ethyl ester
4 Phytol
5 14-hydroxy-15-methyl hexadec-15-enoic acid, ethyl ester
6 Cyclohexane-1-carboxlyic acid, 3-[3-[2-furyl]-1-oxopropyl]-6, 
6-dimethyl-2.4 dioxo-, methyl ester
7 3’,4’,5’-Trimethoxyacetophenone (2- pyridylcarbonyl) hydrazone
8 Tetracosapentaene 2,6,10,15,19,23-hexamethyl No interaction
8
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CONCLUSION
The main objective of this study was to identify the chemical 
constituents from the leaf of P. serratifolia L. This work will help to 
identify the new compounds, which may help to produce important 
therapeutic products. The protein-ligand interaction plays a key 
role in structural-based drug designing. In the present work, eight 
phyto compounds have been identified from ethanol extract of the 
leaves of P. serratifolia L. by GC/MS analysis. The presence of various 
bioactive compounds justifies the use of the leaves of the plant for 
various ailments by traditional practitioners. In this study, we have 
docked the eight bioactive compounds with the active site residues of 
breast cancer protein. Out of 8 compounds, the pentadecanoic acid, 
13-methyl-, methyl ester of P. serratifolia L. had maximum hydrogen 
bond interaction, minimum binding energy value, and maximum dock 
score. Further in-vitro and in-vivo approaches are required to elucidate 
the molecular mechanisms of this compound to find the potentiality 
of the drug against breast cancer. Molecular docking, DFT, and 
Pharmacophore modeling and ADME and toxicity profiles of the newly 
designed compounds were studied and were found to be desirable for 
therapeutics. These compounds appear to be safer even at high doses as 
indicated by the computational studies. With these encouraging results, 
Table 9: Physiochemical properties of compounds identified in P. serratifolia L.
S.No Name CYP2D6 AlogP98 PSA BBB
1 2(1H)-benzocycloctenone, decahydro-10a-methyl-, trans- −3.2955 3.477 17.3 0.647
2 Pentadecanoic acid, 13-methyl-, methyl ester −2.52335 6.414 26.23 1.413
3 Hexadecanoicacid, ethyl ester −0.3881 6.967 26.23 1.584
4 Phytol −1.06037 7.337 20.815 -
5 14-hydroxy-15-methyl hexadec-15-enoic acid, ethyl ester −1.75497 5.921 47.046 0.932
6 Cyclohexane-1-carboxlyic acid, 3-[3-[2-furyl]-1-oxopropyl]-6, 
6-dimethyl-2.4 dioxo-, methyl ester
−3.42607 1.394 87.063 −1.101
7 3’,4’,5’-trimethoxyacetophenone (2-pyridylcarbonyl) hydrazone −5.55845 1.892 79.485 −0.827
8 Tetracosapentaene 2,6,10,15,19,23-hexamethyl −0.01585 11.581 0 -
PSA: Polar surface area, BBB: Blood brain barrier, P. serratifolia: Premna serratifolia
all the compounds can be further explored for structural modification 
and detailed investigations to arrive at possibly newer potent agents 
with better therapeutic effects.
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